While preaching patience, Natixis's Mauricio Giordano told Fund Pro Latin America that Afores could potentially make their first cross-border-fund investments in the second half of 2018.
With holy grail in reach, cross-border managers urge respect for process in Mexico
CCR Monthly Approval Report – December 2017
Products from HSBC, Lyxor, Aberdeen and others won approval, as did the first alternatives products from Carlyle Group, Oaktree Capital and Intermediate Capital Group.
Alternatives registration already underway in Chile
Managers that already have investments via feeder funds can submit their approval directly, while new firms will have to gain sponsorship from an AFP.
CCR Monthly Approval Report – November 2017
iShares, Oddo, Matthews , Lyxor, and Edmond de Rothschild were the fund sponsors gaining approval for new products.
CCR delists commodities products in response to new alternative-investment regime
The risk-rating agency responded to new rules put in place by the Pension authority, whose superintendent. Osvaldo Macías, said: "Investment in commodities will not be allowed at this stage by any modality, or investment in hedge funds."
CCR Monthly Approval Report – October 2017
While First Trust led with four ETFs registered in the month, while AllianceBernstein, Axa, LarrainVial and Credicorp Capital also won approval for funds of their own.
CCR Monthly Approval Report – September 2017
Eurizon led with three mutual funds registered in the month, all of them domiciled in Luxembourg, followed by PineBridge and UBAM, each with two funds approved.
CCR Monthly Approval Report – August 2017
Investec and Morgan Stanley had two products each registered, while JP Morgan and Lord Abbett followed completed the list with one fund each.
CCR Monthly Approval Report – July 2017
Only three products were added in the month from three different asset managers: HSBC, Macquarie and Kames Capital.
CCR Monthly Approval Report – June 2017
UBAM led with four mutual funds registered in the month, three of them bond products, followed by Allianz and Investec, each with one fund approved.




